Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5851–5900 of 18416
On March 14, 2024, Lawrence J. Hineline notified the Company that he intends to retire as Senior Vice President of Finance, Chief Financial Officer, Treasurer and Assistant Secretary of the Company following the appointment of his successor as Chief Financial Officer.
On March 13, 2024, the Board of Directors of International Paper Company (the “Company”) appointed Andrew K. Silvernail, 53, to the position of chief executive officer, effective May 1, 2024 or such other dates as the parties may mutually agree (the “Effective Date”).
Effective as of March 17, 2024, Patrik Jeanmonod stepped down from his position as the Chief Financial Officer of Cytek Biosciences, Inc. (the “Company”) to serve as the Company’s Head of Corporate Development Analytics.
On March 19, 2024, the Board of Directors of the Company announced the appointment of William (“Bill”) McCombe as the Chief Financial Officer of the Company, effective March 18, 2024.
the Company appointed Ms. Lili Dai as interim Chief Financial Officer, to be effective April 1, 2024, with a term ending March 31, 2025.
Mr. Chang has also tendered his resignation on March 18, 2024 from the position of Chief Financial Officer of the Company, to be effective on April 1, 2024.
Upon Ms. Wang’s departure on April 1, 2024, the Company intends to appoint Mr. Sheng-Yih Chang as Chief Executive Officer.
On March 18, 2024, Ms. Rose Hong Wang, Chief Executive Officer of Hartford Great Health Corp. (the “Company”), tendered her resignation from such position effective April 1, 2024.
On March 15, 2024, the Board of Directors appointed Christopher Hsin-Liang Lee as the Chief Financial Officer of Ainos, Inc. (the “Company”).
Ronald Delia notified Amcor plc (the “Company”) of his intention to retire as the Company’s Chief Executive Officer and as a member of the Company’s Board of Directors (the “Board”) for health reasons.
and will become the Chief Executive Officer on July 1, 2024
extended Mr. Shields’ term as Chief Executive Officer to June 30, 2024 in order to facilitate a smooth transition to a new Chief Executive Officer
Kevin J. Wheeler, who has been serving as Chairman, President and Chief Executive Officer of the Company, will continue to serve with the title of Chairman and Chief Executive Officer.
appointed Charles “Chuck” Boynton as the Company’s Chief Financial Officer
On March 13, 2024 (the “Effective Date”), the Company entered into a Separation Agreement (the “Separation Agreement”) with Dr. Bertram.
On March 14, 2024, the Company appointed Nicholas J. Randall as President and Chief Executive Officer of the Company, effective May 1, 2024.
On March 17, 2024, Logitech International S.A. (the “Company” or “Logitech”) announced that Charles Boynton has resigned from his position as Chief Financial Officer of the Company and as a member of its Group Management Team effective May 17, 2024, to pursue another opportunity.
the Board of Directors (the “Board”) of Tile Shop Holdings, Inc. (the “Company”) appointed Mark B. Davis, current Vice President, Investor Relations, and Chief Accounting Officer (Principal Accounting Officer) of the Company, as Senior Vice President, Chief Financial Officer and Secretary of the Company, effective as of April 1, 2024.
On March 15, 2024, the Board of the Company appointed Wayne “Gil” West as Chief Executive Officer of the Company and Hertz, effective as of April 1, 2024.
On March 12, 2024, Stephen M. Scherr, Chair of the Board of Directors (the “Board”) and Chief Executive Officer of Hertz Global Holdings, Inc. (the “Company”) and The Hertz Corporation (“Hertz”) notified the Company of his decision to resign as Chief Executive Officer and as a member of the Board of the Company and Hertz, effective as of March 31, 2024.
On March 14, 2024, the Registrant and Mr. Berg agreed that such resignations will take effect on March 20, 2024.
the Board appointed Kenneth Mushinski as the President and Chief Executive Officer of the Registrant, and as a director of the Registrant, in each case effective as of May 1, 2024.
appointed Alan Ellingson, the Company's Senior Vice President, Finance and Analytics, as the Company's Chief Financial Officer, principal financial officer and principal accounting officer, effective as of May 1, 2024
the Company announced the appointment of Tim Zimmer as the Company’s Chief Executive Officer, effective March 15, 2024.
Mr. Zimmer succeeds Gerard Law, who departed the Company as its Chief Executive Officer, effective March 15, 2024, following notice received that same day.
On March 12, 2024, the board of directors (the “ Board ”) of QT Imaging Holdings, Inc. (the “ Company ”) terminated Dr. John C. Klock from his position as Chief Executive Officer effective as of March 12, 2024.
On March 12, 2024, the Board appointed Dr. Raluca Dinu, who is also a member of the Board, to be employed as its Acting Chief Executive Officer effective as of March 12, 2024.
On February 15, 2024, the board of directors (the “Board”) of Avangrid, Inc. (the “Corporation”), upon the recommendation of its compensation and nominating committee of the Board (the “Compensation and Nominating Committee”), promoted Justin Lagasse to the position of Senior Vice President – Chief Financial Officer and Controller of the Corporation.
the Board appointed Cris Keirn, the Company’s Interim Chief Executive Officer and principal executive officer, to serve as the Company’s Chief Executive Officer and as a director on the Board
On March 14, 2024, Healthcare Triangle, Inc., a Delaware corporation (the “ Company ”), appointed Mr. Anand Kumar, as interim chief executive officer of the Company (the “ Interim CEO ”), effective March 15, 2024
Accordingly, the CEO Agreement expires by its terms on May 26, 2024 (the “ Expiration Date ”) and Mr. O’Brien’s employment as Chief Executive Officer of the Company will terminate as of the Expiration Date.
the Board of Directors (the “Board”) of DallasNews Corporation (the “Company”) appointed Cathy Collins as the Company’s Chief Financial Officer
Ms. Collins succeeds Mary Kathryn Murray, who has served as the Company’s Chief Financial Officer since April 2015. Ms. Murray will continue to serve as President
On March 18, 2024, the board of directors of the Company, appointed Claudio Flamini as Chief Financial Officer of the Company.
The company wishes to thank Rachel Boulds for her hard work and dedication in this role.
the Board appointed Paul Vassilakos as Executive Chairman and Chief Executive Officer of the Company, effective immediately
On March 17, 2024, Kevin O’Donnell resigned as Executive Chairman and Interim Chief Executive Officer of the Company, effective immediately.
Under the Addendum, effective as of March 15, 2024, Mr. Hernon shall resign without Good Reason (as defined in the Hernon Employment Agreement) as the Chief Financial Officer of the Company, and shall instead provide consulting services to the Company pursuant to the terms of the Hernon Consulting Agreement.
In connection with Mr. Hernon’s transition to a consulting role, effective as of March 15, 2024, the Company appointed Leah Lunger as its Interim Chief Financial Officer, interim principal financial officer and interim principal accounting officer.
The board of directors (the “Board”) of Chromocell Therapeutics Corporation (the “Company”) has appointed Francis Knuettel II as Chief Executive Officer of the Company, effective March 13, 2024.
On March 18, 2024, the Company announced that Sean Blitchok will resign upon mutual agreement with the Board as the Company’s Treasurer and Chief Financial Officer, including as principal accounting officer and principal financial officer, effective as of April 1, 2024.
On March 18, 2024, the Company announced that the Board has appointed Laurence E. Katz, age 54, as the Company’s Chief Financial Officer and class I director of the Board, effective upon the commencement of his employment, which is expected to be April 1, 2024.
On March 13, 2024, the Board of Directors of Cognex Corporation (the "Company") designated Laura MacDonald, Vice President of Finance, as the Company's principal financial officer and principal accounting officer on an interim basis, effective March 15, 2024.
On January 3, 2024, the Company announced Mr. Todgham's resignation, effective March 15, 2024
Following the departure of Michael J. DeVito as Freddie Mac’s Chief Executive Officer (CEO) effective March 15, 2024
President Michael T. Hutchins has been appointed to the additional role of interim CEO of the company effective March 16, 2024 and will become a member of Freddie Mac’s Board of Directors on that date.
On March 12, 2024, the Company and Mr. Mauch entered into an amended and restated employment agreement (the “Mauch Employment Agreement”), effective as of the Effective Date.
On March 15, 2024, Gamer Pakistan Inc. (the “Company”) appointed Jerry J. Goldstein as its interim Chief Financial Officer while it conducts a search for a permanent Chief Financial Officer.
The Company’s prior Chief Financial Officer, Mr. Hemant Jain, had died unexpectedly.
the Board elected Brian Windsor, Ph.D., as the Chief Executive Officer of the Company and a member of the Board, effective as of March 11, 2024
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.